Search Results - "Rad, Emilia"

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma by Vary, Antonin, Lebellec, Loïc, Di Fiore, Frédéric, Penel, Nicolas, Cheymol, Claire, Rad, Emilia, El Hajbi, Farid, Lièvre, Astrid, Edeline, Julien, Bimbai, André Michel, Le Deley, Marie-Cécile, Turpin, Anthony

“…Background: Most patients with advanced pancreatic adenocarcinoma (PA) treated with FOLFIRINOX experience adverse events requiring dose reduction. We aimed to…”
Get full text

Pre-therapeutic dihydropyridimidine dehydrogenase (DPD) deficiency screening: Impact on fluoropyrimidine dose reduction at the second chemotherapy cycle and on early severe toxicity by De Metz, Côme, Hennart, Benjamin, Le Deley, Marie-Cecile, Cren, Pierre-Yves, Desauw, Christophe, Bourgeois, Vincent, Laestadius, Fredrik, Rad, Emilia, Lebellec, Loic, Penel, Nicolas, Carnot, Aurelien

“…Abstract only 3096 Background: DPD deficiency screening before fluoropyrimidine is a matter of debate. To avoid lethal toxicity, French authorities impose DPD…”
Get full text

Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer by Hebbar, Mohamed, Di Fioré, Frédéric, Conroy, Thierry, Giraud, Claire, Gasnault, Laurent, Fournier, Charles, Péreira, Renata, Bouché, Olivier, Fournier, Peggy, Deligny, Nathalie, Joly, Jean-Paul, Maes, Patricia, Rad, Emilia, Michel, Pierre, Adenis, Antoine

“…To identify easily available predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer…”
Get more information